Veeva announced fiscal 2027 first quarter results exceeding guidance
Total revenues were $882.9M, up 16% YoY, and subscription revenues grew 15% to $730.2M. The company also raised its fiscal 2027 guidance.
See the latest news and media coverage for Veeva. We track all announcements, press releases, and industry mentions in real time, all in one place.
Industry cloud for life sciences
veeva.comLast updated
In short: Veeva Systems surpassed revenue expectations for fiscal 2027 and accelerated the rollout of its agentic AI platform, Falcon, for drug development.
Total revenues were $882.9M, up 16% YoY, and subscription revenues grew 15% to $730.2M. The company also raised its fiscal 2027 guidance.
Falcon works with Veeva Development Cloud to reduce costs and speed up processes, focusing on trial master file, regulatory correspondence, and safety case triage.
The agentic CRM provides a commercial foundation for the future, integrating into Merck's data ecosystem.
Teva will adopt the agentic CRM globally, leveraging AI to enhance commercial execution.
Evercore ISI cuts Veeva Systems stock price target on valuation changes...
Veeva Systems Inc Class A (NYSE:VEEV) reported stronger-than-expected first-quarter results and...
Veeva Systems Inc Class A (NYSE:VEEV) delivered first-quarter results that exceeded analyst...
What Happened? Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) jumped 7.4% in the afternoon session after the company unveiled Falcon, a new...
Track Veeva and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Veeva and other trending companies.